SU9518 is a selective tyrosine kinase inhibitor targeting PDGFRα, demonstrating significant anti-fibrotic properties. This compound effectively inhibits the progression of proliferative vitreoretinopathy (PVR) in rabbit models involving fibroblasts and Müller cells, showing promising results without discernible toxicity. SU9518 holds potential for therapeutic applications in PVR and other proliferative ocular disorders characterized by fibrosis and gliosis.
SU9518 is a selective tyrosine kinase inhibitor targeting PDGFRα, demonstrating significant anti-fibrotic properties. This compound effectively inhibits the progression of proliferative vitreoretinopathy (PVR) in rabbit models involving fibroblasts and Müller cells, showing promising results without discernible toxicity. SU9518 holds potential for therapeutic applications in PVR and other proliferative ocular disorders characterized by fibrosis and gliosis.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
